Abstract 16784: Under-Enrollment of Real-World Heart Failure With Preserved Ejection Fraction Patients in Major HFpEF Clinical Trials
Joban Vaishnav(Johns Hopkins University), Kavita Sharma(Johns Hopkins University), Virginia S. Hahn(Johns Hopkins University), Rishi Trivedi(Johns Hopkins University), Eunice Yang(Alaska Heart and Vascular Institute), Lisa R. Yanek(Johns Hopkins University), David A. Kass(Johns Hopkins University)
Cited by 0
Related Papers
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
|Nature Medicine|2021|599
Oxidant stress from nitric oxide synthase–3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load
|Journal of Clinical Investigation|2005|445
Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease
|Nature|2015|346
Pivotal role of cardiomyocyte TGF-β signaling in the murine pathological response to sustained pressure overload
|Journal of Clinical Investigation|2011|328
Single-beat estimation of end-diastolic pressure-volume relationship: a novel method with potential for noninvasive application
|American Journal of Physiology-Heart and Circulatory Physiology|2006|301